Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 4.51 USD -2.59% Market Closed
Market Cap: 538.3m USD

P/FCFE
Price to FCFE

-10.5
Current
-11.6
Median
25.4
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-10.5
=
Market Cap
538.3m USD
/
FCFE
-47.6m EUR
Market Cap P/FCFE
DE
Immatics NV
NASDAQ:IMTX
538.3m USD -10.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 107 015.3
US
Abbvie Inc
NYSE:ABBV
369.9B USD 16.9
US
Amgen Inc
NASDAQ:AMGN
167.3B USD 52.2
US
Gilead Sciences Inc
NASDAQ:GILD
139.6B USD 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.6B USD -131.7
US
Epizyme Inc
F:EPE
94.1B EUR -441.6
AU
CSL Ltd
ASX:CSL
121B AUD 53.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.5B USD 19.9
US
Seagen Inc
F:SGT
39.3B EUR -60.7
NL
argenx SE
XBRU:ARGX
32.3B EUR -105
 
DE
Immatics NV
NASDAQ:IMTX
Average P/FCFE: 31
Negative Multiple: -10.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 107 015.3
US
Abbvie Inc
NYSE:ABBV
16.9
US
Amgen Inc
NASDAQ:AMGN
52.2
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -131.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -441.6
AU
CSL Ltd
ASX:CSL
53.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A